PCRX
NASDAQ · Pharmaceuticals
Pacira Biosciences Inc
$24.69
+0.21 (+0.86%)
Open$24.36
Previous Close$24.48
Day High$24.72
Day Low$24.20
52W High$27.66
52W Low$18.80
Volume—
Avg Volume570.6K
Market Cap975.82M
P/E Ratio66.66
EPS$0.35
SectorPharmaceuticals
Analyst Ratings
Buy
13 analysts
Price Target
-8.0% upside
Current
$24.69
$24.69
Target
$22.71
$22.71
$15.64
$22.71 avg
$35.67
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 620.56M | 603.07M | 216.59M |
| Net Income | 6.01M | 5.26M | 41.33M |
| Profit Margin | 1.0% | 0.9% | 19.1% |
| EBITDA | 55.10M | 50.87M | 75.27M |
| Free Cash Flow | — | — | 28.35M |
| Rev Growth | +2.9% | +2.9% | +14.7% |
| Debt/Equity | 0.54 | 0.54 | 0.92 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |